Abstract
The clinical considerations include discussion on:
- administration
- Vaccination of persons with prior SARSCoV-2 infection or exposure
- Vaccination of special populations
- Patient vaccine counseling
- Contraindications and precautions
- Interpretation of SARS-CoV-2 test results in vaccinated person
These considerations have been presented at the ACIP extraordinary meeting on December 12, 2020.
Background paper
Americas
United States of America
Pfizer-BioNTech vaccine
COVID-19
